Fulcrum Therapeutics, Inc.

FULC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Apr 19, 2024 DEFA14A
DEF 14A Apr 19, 2024 DEF 14A
4 Mar 20, 2024 4
3 Mar 20, 2024 3
4 Mar 8, 2024 4
144 Mar 8, 2024
4 Mar 5, 2024 4
UPLOAD Mar 1, 2024
S-8 Feb 27, 2024 S-8
S-3 Feb 27, 2024 S-3
10-K Feb 27, 2024 10-K
8-K Feb 27, 2024 8-K
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G/A Feb 14, 2024 FULCRUM THERAPEUTICS, INC.
SC 13G/A Feb 13, 2024
SC 13G/A Feb 9, 2024
SC 13G/A Feb 7, 2024 FULCRUM THERAPEUTICS, INC.
4 Jan 30, 2024 4
4 Jan 30, 2024 4
4 Jan 30, 2024 4
4 Jan 19, 2024 4
10-Q Nov 7, 2023 10-Q
8-K Nov 7, 2023 8-K
8-K Oct 2, 2023 8-K
← Newer Page 7 of 21 · 513 filings Older →